These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9262530)

  • 1. The serum digoxin concentration: ten questions to ask.
    Cauffield JS; Gums JG; Grauer K
    Am Fam Physician; 1997 Aug; 56(2):495-503, 509-10. PubMed ID: 9262530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin?
    Cohen E; Almog S; Staruvin D; Garty M
    Isr Med Assoc J; 2002 Oct; 4(10):772-5. PubMed ID: 12389338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of exenatide on the steady-state pharmacokinetics of digoxin.
    Kothare PA; Soon DK; Linnebjerg H; Park S; Chan C; Yeo A; Lim M; Mace KF; Wise SD
    J Clin Pharmacol; 2005 Sep; 45(9):1032-7. PubMed ID: 16100297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Posologic factors of digoxin in Catalonia].
    Navarro Moreno LA; Maldonado Pardo R; García González I; Reig Puig L
    An Med Interna; 1999 Oct; 16(10):543-4. PubMed ID: 10603679
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration.
    DeVore KJ; Hobbs RA
    Pharmacotherapy; 2007 Mar; 27(3):472-5. PubMed ID: 17316159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and application of a 96-well format solid-phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of digoxin in human plasma.
    Hashimoto Y; Shibakawa K; Nakade S; Miyata Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):126-32. PubMed ID: 18515196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lasofoxifene on the pharmacokinetics of digoxin in healthy postmenopausal women.
    Roman D; Bramson C; Ouellet D; Randinitis E; Gardner M
    J Clin Pharmacol; 2005 Dec; 45(12):1407-12. PubMed ID: 16291716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The practice of digoxin therapeutic drug monitoring.
    Barclay M; Begg E
    N Z Med J; 2003 Dec; 116(1187):U704. PubMed ID: 14752532
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of coadministration on the pharmacokinetics of azimilide dihydrochloride and digoxin.
    Toothaker RD; Corey AE; Valentine SN; Agnew JR; Parekh N; Moehrke W; Thompson GA; Powell JH
    J Clin Pharmacol; 2005 Jul; 45(7):773-80. PubMed ID: 15951467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The dosage of cardiotonic agents in infants as a function of their serum levels and pharmacokinetics].
    Nanulescu M; Leucuţa S; Bucerzan C; Samir A; Szabó P
    Rev Pediatr Obstet Ginecol Pediatr; 1990; 39(1):89-94. PubMed ID: 2128721
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin may reduce the mortality rates in patients with congestive heart failure.
    Wang L; Song S
    Med Hypotheses; 2005; 64(1):124-6. PubMed ID: 15533628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between high serum digoxin levels and toxicity.
    Tuncok Y; Hazan E; Oto O; Guven H; Catalyurek H; Kalkan S
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):366-8. PubMed ID: 9314088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil.
    Verschraagen M; Koks CH; Schellens JH; Beijnen JH
    Pharmacol Res; 1999 Oct; 40(4):301-6. PubMed ID: 10527640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin prescribing for heart failure in elderly residents of long-term care facilities.
    Misiaszek B; Heckman GA; Merali F; Turpie ID; Patterson CJ; Flett N; McKelvie RS
    Can J Cardiol; 2005 Mar; 21(3):281-6. PubMed ID: 15776118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changed digitalis dosing].
    Reikvam A
    Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1324. PubMed ID: 20596094
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetics of digoxin in hyperthyroidism. Effect of methimazole].
    Izbicka M; Gasińska T; Dec R
    Wiad Lek; 2010; 63(1):10-6. PubMed ID: 20701025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the appropriateness of serum digoxin concentration measurement in a medical group setting.
    Orrico KB; Wu M; Wilson AR
    J Manag Care Pharm; 2011 Nov; 17(9):695-700. PubMed ID: 22050394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.